ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint746,952 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch instituteBaarApellis Schweiz GmbH
Apellis Schweiz GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Apellis Schweiz GmbH is a biopharmaceutical company that develops medicines that inhibit the complement cascade, with a particular focus on the complement protein C3. Its pipeline and approved products target conditions such as geographic atrophy, C3 glomerulopathy/primary immune complex‑mediated membranoproliferative glomerulonephritis, and paroxysmal nocturnal hemoglobinuria, and the site cites products including Empaveli and Syfovre.

AI-generated
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Apellis Schweiz GmbH

Offering

Products & services

Industry:Research institute
✓ Offered2
Drug therapies for rare diseases and geographic atrophy
Drug therapies for rare diseases and geographic atrophy; information on the products EMPAVELI and SYFOVRE, as well as the related product information and support offerings.
Patient and caregiver information
Information and resources for patients on the therapies, the focus areas, and access to further content via the patient page.
Trust & reputation

ranQ Trust Score of Apellis Schweiz GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Apellis Schweiz GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Apellis Schweiz GmbH scores 68.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.50.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Apellis Schweiz GmbH scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Apellis Schweiz GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Apellis Schweiz GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Apellis Schweiz GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Apellis Schweiz GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Apellis Schweiz GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Apellis Schweiz GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Neuhofstrasse 30
6340 Baar
Opening hours
Mon
09:00 - 17:30
Tue
09:00 - 17:30
Wed
09:00 - 17:30
Thu
09:00 - 17:30
Fri
09:00 - 17:30
Sat
Closed
Sun
Closed

At a glance

Legal form
Limited Liability Company
UID
CHE-292.609.279
Founded
2023 · 3 years
Last commercial register change
October 9, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AP
    Alexion Pharma GmbH
    Baar
    CL
    Centenara Labs AG
    Baar
    1A
    1abtik ag
    Baar
    RP
    Rhythm Pharmaceuticals Switzerland GmbH
    Zug
    SI
    Sarepta International Holdings GmbH
    Zug
    SR
    Scholar Rock Switzerland GmbH
    Zug
    CT
    CRISPR Therapeutics AG
    Zug
    IS
    Insmed Switzerland GmbH
    Zug